Gvr Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 2.00 Cr
- Company Age 11 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 6.95 Cr
- Revenue Growth 5.99%
- Profit Growth 53.54%
- Ebitda 30.12%
- Net Worth 7.82%
- Total Assets -5.50%
About Gvr Pharma
Gvr Pharma Private Limited (GPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 18 December 2013 and has a history of 11 years and one month. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company has closed loans amounting to ₹6.95 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Lakkireddy Reddy and Jyothi Lakkireddy serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24232TG2013PTC091784
- Company No.
091784
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Dec 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Gvr Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lakkireddy Reddy  | Director | 18-Dec-2013 | Current |
| Jyothi Lakkireddy | Director | 18-Dec-2013 | Current |
Financial Performance of Gvr Pharma.
Gvr Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.99% increase. The company also saw a substantial improvement in profitability, with a 53.54% increase in profit. The company's net worth moved up by a moderate rise of 7.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gvr Pharma?
In 2023, Gvr Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Madhav Biotech Private LimitedLakkireddy Reddy and Jyothi Lakkireddy are mutual person
- Vensat Bio Private Limited
Lakkireddy Reddy is a mutual person
Charges (Loans)
₹0
₹6.95 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 4.65 Cr
- State Bank Of Hyderabad : 2.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Oct 2017 | State Bank Of India | ₹4.65 Cr | Satisfied |
| 14 Jan 2016 | State Bank Of Hyderabad | ₹2.30 Cr | Satisfied |
How Many Employees Work at Gvr Pharma?
Unlock and access historical data on people associated with Gvr Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gvr Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gvr Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.